TransSafeTM Mycoplasma Prevention Reagent
支原體預防試劑
目錄號： FM501-01
單 價：￥290
產品詳情介紹
本產品是對支原體具有抑制作用的三種抗生素的混合物，分別為大環內酯類、氟喹諾酮類和四環素類衍生物抗生素，可以有效干擾支原體的蛋白表達和 DNA復制。本產品可以有效地預防細胞培養過程中支原體的污染，同時還能預防常見的革蘭氏陽性菌和陰性菌，日常細胞培養中替代雙抗使用效果更好，作用濃度低，幾乎沒有細胞毒性。
支原體介紹視頻
1.Wang S, Han Q, Qin W, et al. PhenoModel: A multimodal phenotypic drug design foundation model for discovering novel potential inhibitors of multiple cancer cells[J]. Acta Pharmaceutica Sinica B, 2025.(IF 14.80)
2.Zhang Y, Li Y, Zhang Z, et al. CD49a targeting enhances NK cell function and antitumor immunity[J]. Cancer Immunology Research, 2025, (IF 8.20)
3.Gao J, Li C, Wang X, et al. Oridonin attenuates lung inflammation and fibrosis in silicosis via covalent targeting iNOS[J]. Biomedicine & Pharmacotherapy, 2022.(IF 7.50)
4.Ye H, Kang L, Yan X, et al. MiR-103a-3p promotes Zika virus replication by targeting OTU Deubiquitinase 4 to activate p38 mitogen-activated protein kinase signaling pathway[J]. Frontiers in Microbiology, 2022.(IF 6.06)
